Undervalued Stocks Based on Big Data: Returns up to 70.55% in 1 Year

Undervalued Stocks

The Fundamental Package includes our algorithmic forecasts for stocks screened by fundamental criteria. Our algorithms help you find best opportunities for both long and short positions for the stocks within each fundamental screen. The stocks are selected according to five basic valuation categories:

  • P/E (price to earnings ratio)
  • PEG (price/earnings to growth ratio)
  • price-to-book ratio
  • price-to-sales ratio
  • short ratio

fundamentals
Package Name: Fundamental – High PEG Stocks
Recommended Positions: Long
Forecast Length: 1 Year (5/30/2019 – 5/30/2020)
I Know First Average: 24.38%
Undervalued Stocks
Undervalued Stocks chart

In this 1 Year forecast for the Fundamental – High PEG Stocks Package, there were many high performing trades and the algorithm correctly predicted 7 out 10 trades. BIO was our best stock pick this week a return of 70.55%. SNPS and CBM also performed well for this time horizon with returns of 55.66% and 46.89%, respectively. The package had an overall average return of 24.38%, providing investors with a premium of 14.99% over the S&P 500’s return of 9.39% during the same period.

Bio-Rad Laboratories, Inc. (BIO) manufactures and supplies a range of reagents, apparatus, and equipment to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network. It has operations in Europe, Pacific Rim, the United States, Canada, Latin America, and internationally. Bio-Rad Laboratories, Inc. (BIO) was founded in 1952 and is headquartered in Hercules, California.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.